Somnoware has been selected as a UCSF Digital Health Award Finalist in the Clinical Diagnostic Tool/Platform category. The Awards honor outstanding health technologies and innovations dramatically transforming healthcare. Somnoware is one of four Best in Class Finalists.
The Clinical Diagnostic Tool/Platform category recognizes a digital diagnostic technology for patient monitoring that can significantly improve decision-making in the clinical setting.
Daniel Kraft, MD, Founder of Digital.Health, led a live discussion with the finalists in the Remote Diagnostic Tool or Device, Clinical Diagnostic Tool and Mental & Behavioral Health categories on current trends in the digital health field.
“Some incredible finalists in the UCSF Health Hub Digital Health Awards, both in the ‘Best in Class’ and ‘Rising Stars’ categories,” Kraft stated in a post. “It’s encouraging to see the array of innovative and impactful companies across the diverse #DigitalHealth care continuum.”
The UCSF Digital Health Awards seek the best companies that are revolutionizing digital health and therapeutics, across 11 selected award categories. Each year the organization awards the best of the best in digital health as voted by industry experts across academia, industry, the investment community, and industry analysts.
Somnoware is a cloud-based platform for enhanced respiratory care management. The platform orchestrates data flow between disparate medical devices, unifies datasets within a single platform, and delivers high-impact analytics. The solution enables screening, faster diagnosis, proactive intervention, and automated patient engagement, resulting in improved treatment outcomes for patients with sleep disorders and respiratory diseases, including COPD.
Visit somnoware.com to request a demo of the platform.
Franklin Holman is director of marketing at Somnoware. He can be reached at email@example.com.